Bioworld have published an article on Tiziana Life Sciences SPMS 6-month data using intranasal foralumab.
Article: Single-patient data suggest Tiziana nose a better way with CD3 in MS
Related documents Bioworld Article
Bioworld have published an article on Tiziana Life Sciences SPMS 6-month data using intranasal foralumab.